Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 6—June 2020

Melioidosis in a Resident of Texas with No Recent Travel History, United States

Caitlin M. CossaboomComments to Author , Atanaska Marinova-Petkova, Jonathan Strysko, Gretchen Rodriguez, Trevor Maness, Jaime Ocampo, Jay E. Gee, Mindy G. Elrod, Christopher A. Gulvik, Lindy Liu, William A. Bower, Alex R. Hoffmaster, David D. Blaney, Johanna S. Salzer, Jonathan S. Yoder, Mia C. Mattioli, Thomas J. Sidwa, Lillian Ringsdorf, Gale Morrow, Elvia Ledezma, and Amanda Kieffer
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.M. Cossaboom, A. Marinova-Petkova, J. Strysko, J.E. Gee, M.G. Elrod, C.A. Gulvik, L. Liu, W.A. Bower, A.R. Hoffmaster, D.D. Blaney, J.S. Salzer, J.S. Yoder, M.C.Mattioli); Texas Department of State Health Services, San Antonio, Texas, USA (G. Rodriguez, T. Maness, J. Ocampo, L. Ringsdorf, G. Morrow, E. Ledezma, A. Kieffer); Texas Department of State Health Services, Austin, Texas, USA (T.J. Sidwa)

Main Article


Drug susceptibility profile for Burkholderia pseudomallei isolate from culture of chest wound from a 63-year-old man, Texas, USA*

Drug MIC, μg/mL Result
Amikacin >32 R
Ampicillin >16 R
Ampicillin/sulbactam >16/8 R
Aztreonam >16 R
Cefazolin >16 R
Cefepime >16 R
Cefotaxime 32 R
Cefoxitin >16 R
Ceftazidime 8 S
Ceftriaxone >32 R
Cefuroxime >16 R
Ciprofloxacin >2 R
Gentamicin >8 R
Ertapenem >1 R
Meropenem <1 S
Piperacillin/tazobactam <16 S
Tobramycin >8 R
Trimethoprim/sulfamethoxazole <2/38 S

*R, resistant; S, susceptible.

Main Article

Page created: May 19, 2020
Page updated: May 19, 2020
Page reviewed: May 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.